2024-01-17 REL RCSB RCSB RCSB 2021-10-19 2022-05-04 2022-05-04 2024-01-17 Jack Ma Foundation China Antibody 11-11 in complex with prefusion SARS-CoV-2 B.1.351 Spike glycoprotein Casner RG Shapiro L spike glycoprotein, antibody, VIRAL PROTEIN Liu L Iketani S Guo Y Reddem ER Casner RG Nair MS Yu J Chan JF Wang M Cerutti G Li Z Morano NC Castagna CD Corredor L Chu H Yuan S Poon VK Chan CC Chen Z Luo Y Cunningham M Chavez A Yin MT Perlin DS Tsuji M Yuen KY Kwong PD Sheng Z Huang Y Shapiro L Ho DD An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses. Sci Transl Med US 14 eabn6859 eabn6859 2022 35438546 doi:10.1126/scitranslmed.abn6859 1946-6242 EMD-25146 other EM volume
related antibody 10-40
 EMD-25166 other EM volume
related antibody 10-28
 Antibody 11-11 in complex with prefusion SARS-CoV-2 B.1.351 Spike glycoprotein Antibody 11-11 in complex with prefusion SARS-CoV-2 B.1.351 Spike glycoprotein 0 1 2 3 Severe acute respiratory syndrome coronavirus 2 spike glycoprotein Severe acute respiratory syndrome coronavirus 2 Homo sapiens LEVO MFVFLVLLPLVSSQCVNFTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFANPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRGLPQGFSALEPLVDLPIGINITRFQTLHISYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGNIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVKGFNCYFPLQSYGFQPTYGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPGSASSVASQSIIAYTMSLGVENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDPPEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQ antibody 11-11 heavy chain Homo sapiens Homo sapiens LEVO QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGGYYWSWIRQHPGKGLEWIGYIYYSGSTY YNPSLKSRVTISVDTSKNQFSLKVSSVTAADTAVYYCASSNYYDGSGYNLLESYGMDVWG QGTSVTVSS antibody 11-11 light chain Homo sapiens Homo sapiens LEVO QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGV PDRFSGSRSGTSASLAITGLQAEDEADYYCQSYDSSLSGSWVFGGGTKVTVL singleParticle particle 1 5.5 150.0 NaCl Sodium Chloride 10.0 Sodium Acetate 0.005 DDM C-flat-1.2/1.3 300 GLOW DISCHARGE ETHANE 100 293 FEI VITROBOT MARK IV FEI TITAN KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 GATAN K3 BIOQUANTUM (6k x 4k) 2.4 42.0 1
Ab initio
 6.4 FSC 0.143 CUT-OFF cryoSPARC v3.2.0
Value reported by cryoSPARC FSC calculation with a "loose" mask.
281235 MAXIMUM LIKELIHOOD MAXIMUM LIKELIHOOD emd_25167.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 384 384 384 0 0 0 384 384 384 410.88 410.88 410.88 90.0 90.0 90.0 X Y Z -0.09099302 0.28549317 -0.00024136729 0.012746604 1.07 1.07 1.07 0.06 AUTHOR 2-Fab-Bound map emd_25167_additional_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 128 128 128 0 0 0 128 128 128 471.04 471.04 471.04 90.0 90.0 90.0 X Y Z -0.36330387 1.4265519 -0.00094428874 0.05334559 3.68 3.68 3.68 AUTHOR 3-Fab-Bound map with 3 RBD UP emd_25167_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 384 384 384 0 0 0 384 384 384 410.88 410.88 410.88 90.0 90.0 90.0 X Y Z -0.5950741 0.6028539 0.00049335393 0.07392748 1.07 1.07 1.07 AUTHOR emd_25167_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 384 384 384 0 0 0 384 384 384 410.88 410.88 410.88 90.0 90.0 90.0 X Y Z -0.5866909 0.6498606 0.00049968425 0.073917195 1.07 1.07 1.07 AUTHOR